title: Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?
authors: L
authors: L
authors: Barzon
authors: F
authors: F
authors: Fallo
authors: N
authors: N
authors: Sonino
authors: O
authors: O
authors: Daniele
authors: M
authors: M
authors: Boscaro
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000188:drug therapy*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008297:Male; D008939:Mitotane / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane